Benson, John, Chen, Ying-Nan, Cornell-Kennon, Susan, Dorsch, Marion, Kim, Sunkyu, Leszczyniecka, Magdalena, Sellers, William and Lengauer, Christoph (2006) Validating cancer drug targets. Nature, 441 (7092). pp. 451-456. ISSN 1476-4687

Abstract

A cancer drug target is only truly validated by demonstrating that a given therapeutic agent is clinically effective and acts through the target against which it was designed. Nevertheless, it is desirable to declare an early-stage drug target as 'validated' before investing in a full-scale drug discovery programme dedicated to it. Although the outcome of validation studies can guide cancer research programmes, strictly defined universal validation criteria have not been established.

Item Type:	Article
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez...
Additional Information:	author can archive post-print (ie final draft post-refereeing); Publisher's version/PDF cannot be used
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez...
Date Deposited:	14 Dec 2009 14:00
Last Modified:	31 Jan 2013 01:18
URI:	https://oak.novartis.com/id/eprint/405